Perspective Therapeutics Statistics
Share Statistics
Perspective Therapeutics has 74.23M
shares outstanding. The number of shares has increased by 9.82%
in one year.
| Shares Outstanding | 74.23M |
| Shares Change (YoY) | 9.82% |
| Shares Change (QoQ) | 9.56% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,564 |
| FTD / Avg. Volume | 0.74% |
Short Selling Information
The latest short interest is 5.27M, so 7.11% of the outstanding
shares have been sold short.
| Short Interest | 5.27M |
| Short % of Shares Out | 7.11% |
| Short % of Float | 10.08% |
| Short Ratio (days to cover) | 7.65 |
Valuation Ratios
The PE ratio is -2.59 and the forward
PE ratio is -1.97.
Perspective Therapeutics's PEG ratio is
0.09.
| PE Ratio | -2.59 |
| Forward PE | -1.97 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 0.71 |
| P/FCF Ratio | -2.83 |
| PEG Ratio | 0.09 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Perspective Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.68,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.68 |
| Quick Ratio | 12.68 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | -0.03 |
| Interest Coverage | -217.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-574,485.51 |
| Employee Count | 138 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.1M |
| Effective Tax Rate | 2.58% |
Stock Price Statistics
The stock price has increased by -84% in the
last 52 weeks. The beta is 1.13, so Perspective Therapeutics's
price volatility has been higher than the market average.
| Beta | 1.13 |
| 52-Week Price Change | -84% |
| 50-Day Moving Average | 2.29 |
| 200-Day Moving Average | 6.61 |
| Relative Strength Index (RSI) | 49.18 |
| Average Volume (20 Days) | 752,311 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | 10.46M |
| Net Income | -79.28M |
| EBITDA | 10.46M |
| EBIT | -81.42M |
| Earnings Per Share (EPS) | -1.23 |
Full Income StatementBalance Sheet
The company has 61.58M in cash and 2.38M in
debt, giving a net cash position of 59.2M.
| Cash & Cash Equivalents | 61.58M |
| Total Debt | 2.38M |
| Net Cash | 59.2M |
| Retained Earnings | -231.72M |
| Total Assets | 341.1M |
| Working Capital | 212.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -18.29M
and capital expenditures -54.41M, giving a free cash flow of -72.71M.
| Operating Cash Flow | -18.29M |
| Capital Expenditures | -54.41M |
| Free Cash Flow | -72.71M |
| FCF Per Share | -1.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
